| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 213,814 | 211,161 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 8,053 | 4,643 |
| Cash and cash equivalents at beginning of period | 30,532 | - |
| Cash and cash equivalents at end of period | 38,585 | - |
Beta Bionics, Inc. (BBNX)
Beta Bionics, Inc. (BBNX)